Research Article
Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression
Table 1
Clinical and pathological characteristics of uveal melanoma patients at the time of diagnosis. Missing data is marked as NA (not available).
| | Characteristics | Training cohort (TCGA-UVM, ) | Testing cohort (GSE22138, ) |
| | Age at diagnosis (years) | | | | Mean (SD) | 61 (14) | 61 (13) | | Min-max | 22-86 | 29-85 | | Gender | | | | Female | 31 (43.66%) | 22 (36.67%) | | Male | 40 (56.34%) | 38 (63.33%) | | Clinical stage | | | | I | 0 (0.00%) | NA | | II | 31 (43.66%) | NA | | III | 36 (50.71%) | NA | | IV | 4 (5.63%) | NA | | T classification | | | | T1 | 0 (0.00%) | NA | | T2 | 3 (4.22%) | NA | | T3 | 32 (45.07%) | NA | | T4 | 34 (47.89%) | NA | | Tx | 2 (2.82%) | NA | | N classification | | | | N0 | 67 (94.37%) | NA | | N1 | 0 (0.00%) | NA | | Nx | 4 (5.63%) | NA | | M classification | | | | M0 | 64 (90.14%) | NA | | M1 | 3 (4.22%) | NA | | Mx | 4 (5.63%) | NA | | Extrascleral extension | | | | No | 60 (84.51%) | 47 (78.33%) | | Yes | 7 (9.86%) | 4 (6.67%) | | Unknown | 4 (5.63%) | 9 (15.00%) | | Tumor basal diameter (mm) | | | | Mean (SD) | 17 (4) | 15 (4) | | Range | 8-25 | 9-23 | | Tumor thickness (mm) | | | | Mean (SD) | 11 (3) | 12 (2) | | Range | 4-16 | 6-17 |
|
|
